• 1
    Kobayashi T, Saji T, Otani T et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet; 379: 16131620.
  • 2
    Newburger JW, Sleeper LA, McCrindle BW et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N. Engl J. Med. 2007; 356: 663675.
  • 3
    Son MBF, Newburger JW. Management of Kawasaki disease: corticosteroids revisited. Lancet; 379: 15711572.
  • 4
    Sleeper LA, Minich LL, McCrindle BM et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J. Pediatr. 2011; 158: 831835.